Mr. Karikari-Boateng brings extensive expertise in regulatory affairs, pharmaceutical manufacturing, and quality assurance, with a proven track record of strengthening regulatory frameworks and building capacity across Africa. Prior to this role, he served as Director of Laboratories at the Ghana Food and Drug Authority (FDA). Under his leadership, Ghana became the first country to approve the R21 malaria vaccine.

He has been a prominent figure in regulatory forums, including the African Medicines Regulatory Harmonization (AMRH) initiative and the African Vaccine Regulation Forum (AVAREF), where he chairs the Biologics Regulation Forum. His contributions with the World Health Organization (WHO) and the European Medicines Agency (EMA) include evaluating groundbreaking products. Furthermore, Mr. Karikari-Boateng chairs the Expert Working Group for Biologics in WAHO (West African Health Organization).